An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"
Conditions
- P. Aeruginosa
- Baumannii
- Klebsiella Pneumonia
- E.coli Infections
- Enterococcus Faecalis Infection
- Chronic Bacterial Cystitis
Interventions
- DRUG: Fluorothiazinone, tablets 300 mg
- DRUG: Nitrofurantoin 100 MG
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation